{
    "code": "02023302",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023302",
    "time": "2021-08-27 06:02:37",
    "許可證字號": "衛署藥輸字第023302號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/10\/25",
    "發證日期": "90\/10\/25",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202330200",
    "中文品名": "氯氮平〝普佛馬可〞",
    "英文品名": "CLOZAPINE",
    "適應症": "精神安定劑。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CLOZAPINE",
    "限制項目": "02輸　入",
    "申請商名稱": "0801701100  東信化學藥品有限公司",
    "申請商地址": "台北市吉林路４５號６樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIT0107000  CAMBREX PROFARMACO MILANO S.R.L.",
            "製造廠廠址": "PAULLO (MI), VIA CURIEL 34, ITLAY",
            "製造廠公司地址": "PAULLO (MI), VIA CURIEL 34, ITLAY",
            "製造廠國別": "ITALY",
            "製程": ""
        }
    ],
    "CCC號列": "29332900005 其他之結構中含有一未稠合之咪唑環（不論是否氫化）之化合物Other compounds containing an unfused imidazole ring (whether or not hydrogened) in the structure",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816901600",
            "成分名稱": "CLOZAPINE",
            "含量描述": "Clozapine contains not less than 99.0% and not more than 101.0% of C18H19ClN4, calculated with reference to the dried substance.",
            "含量": "0.0000000000",
            "單位": "%"
        }
    ]
}